Experimental Study of LY333328 (Oritavancin), Alone and in Combination, in Therapy of Cephalosporin-Resistant Pneumococcal Meningitis

Using a rabbit model of meningitis, we sought to determine the efficacy of LY333328, a semisynthetic glycopeptide, in the treatment of cephalosporin-resistant pneumococcal meningitis. LY333328 was administered at a dose of 10 mg/kg of body weight/day, alone and in combination with ceftriaxone at 100...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cabellos, Carmen, Fernàndez, Antonio, Maiques, Jose M., Tubau, Fe, Ardanuy, Carmen, Viladrich, Pedro F., Liñares, Josefina, Gudiol, Francesc
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2003
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC155831/
https://ncbi.nlm.nih.gov/pubmed/12760866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.6.1907-1911.2003
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia